Euroapi Sa · EURONEXT:EAPI
Euroapi Sa — Shareholder Meeting (April 2026)
15 slides from Euroapi Sa's shareholder meeting presentation, Apr 28, 2026
Slide 1: 2026 AGM Governance Roadshows
2026 AGM Governance Roadshows Emmanuel Blin Chair of the Board Elizabeth Bastoni Chair of the Remuneration & Nominations Committee
Slide 2: Executive Summary
Executive Summary Governance Staggering of Directors’ terms of Office and Board Appointment of Tristan Imbert as Independent Director Composition Corporate Chair of the Board and CEO fixed remuneration unchanged Officers CEO 2026 variable compensation aligned with the execution of FOCUS-27 Remunerat
Slide 3: Staggering of Directors' terms of Office
Staggering of Directors’ terms of Office AGM approving 2026 financial statements Elizabeth Bastoni Jean-Yves Caminade Tristan Imbert (One-year Independent BPIfrance Independent mandate) AGM approving 2027 financial statements Cécile Dussart Olivier Klaric (Two-years Independent Sanofi mandate) AGM a
Slide 4: Board composition at the end of 2025
Board composition at the end of 2025 Emmanuel Blin 5 Independent Directors Chair of the Board 2 Directors representing the employees 63% 55 Independents average-aged Elizabeth Bastoni Cécile Dussart Mattias Perjos Tristan Imbert 40% 4 women Nationalities Olivier Klaric Géraldine Leveau Jean-Yves Kev
Slide 5: Board's activity in 2025
Board’s activity in 2025 Main topics covered/reviewed Board evaluation Strategy and growth, including evaluation of strategic Self-assessment conducted through an electronic options questionnaire to all the Directors Focus-27 execution plan List of items for improvements approved by the Boar
Slide 6: The Board's Committees
The Board’s Committees REMUNERATION AND AUDIT COMMITTEE ESG COMMITTEE NOMINATIONS COMMITTEE 5 100% 67% 5 95% 67% 3 92% 67% meetings Attendance Independence meetings Attendance Independence meetings Attendance Independence rate rate rate rate rate rate Tristan Imbert Elizabeth Bastoni Cécile Dussart
Slide 7: 2025 Remunerations (ex-post)
2025 Remunerations (ex-post) Independent Directors Chair of the Board Resolution #14 Resolution #15 €396,784 Fixed Total enveloppe Remuneration €450,000 €270,000 7
Slide 8: 2025 Remunerations (ex-post)
2025 Remunerations (ex-post) David Seignolle Resolution #16 Euros Weighting Achievement Fixed Remuneration 485,000 Free Cash Flow before Financing 25% 150% Core EBITDA margin 25% 60% Variable Remuneration 397,700 ESG 10% 100% Continue and accelerate the delivery Defined Contribution plan 25% 100% 72
Slide 9: 2025 Remunerations (ex-post)
2025 Remunerations (ex-post) Ludwig De Mot (remaining balance) Resolution #17 Amount approved Remaining Amount due for Euros by the 2025 AGM balance to be 2024 and paid in 2025 approved Remaining balance of remuneration paid to Ludwig Variable de Mot, in respect of his office as Chief Executive Remu
Slide 10: 2026 Remuneration Policy (ex-ante)
2026 Remuneration Policy (ex-ante) Independent Directors Chair of the Board Resolution #18 Resolution #19 Total envelope €450,000 (unchanged) Remuneration unchanged Independent Independent Directors – Committee Members Directors Additional Audit & compensation Remuneration/Nominations ESG of €4,000
Slide 11: 2026 Remuneration Policy (ex-ante)
2026 Remuneration Policy (ex-ante) Chief Executive Officer – David Seignolle Resolution #20 Financial Targets (Based on 2026 Budget) Free Cash Flow 25% €485,000 Variable Core EBITDA margin 25% ESG 10% Target 80% of fixed Individual Objectives remuneration with 120% maximum Implement a commercial tur
Slide 12: CEO Long Term Remuneration
CEO Long Term Remuneration Performance Share Grant Existing plan Future plan (Resolution #24) Authorization given to the Board of Directors to grant free shares of the Company to employees and corporate officers, up to a maximum of 3.6% of the share capital, of which up to 1.0% may Stock Options be
Slide 13: Resolutions
Resolutions Ordinary General Meeting 1. Approval of the parent company financial statements for 5. Renewal of Mr. Emmanuel Blin’s term of office as director, the year ended December 31, 2025; 6. Renewal of Ms. Elizabeth Bastoni’s term of office as director, 2. Approval of the consolidated financial
Slide 14: Resolutions
Resolutions Ordinary General Meeting 14. Approval of the information referred to in article L. 22-10-9, 17. Approval of the variable components of the remaining balance of paragraph I of the French Commercial Code relating to remuneration paid during the financial year ended December 31, remuneratio
Slide 15: Resolutions
Resolutions Extraordinary General Meeting 23. Authorization for the board of directors to reduce the share capital 25. Powers for formalities. by cancelling shares under the authorization to repurchase the Company's own shares, 24. Authorization to be granted to the board of directors to grant free